# A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

> **NCT06223048** · PHASE2 · RECRUITING · sponsor: **Amydis Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Primary Open Angle Glaucoma

## Interventions

- **DRUG:** AMDX-2011P

## Key facts

- **NCT ID:** NCT06223048
- **Lead sponsor:** Amydis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-07
- **Primary completion:** 2024-11
- **Final completion:** 2025-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06223048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06223048, "A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06223048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*